BB Biotech AG earnings
Annual earnings per share (CHF per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2022 | 2022-12-31 | CHF -6.50 | CHF -6.50 | 2026-06-19T05:58:58Z |
| 2021 | 2021-12-31 | CHF -7.31 | CHF -7.31 | 2026-06-19T05:58:58Z |
Revenue & profit (CHF)
| Concept | 2022 | 2021 |
|---|---|---|
| Revenue | — | — |
| Profit for the year | -CHF 357.8M | -CHF 404.8M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in BB Biotech AG's ESEF annual reports (source:
filings.xbrl.org).
Figures are in CHF, as reported. Not investment advice.